Search Results - "Cerdas, Sonia"

Refine Results
  1. 1
  2. 2

    Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus by Wilding, John P.H, Blonde, Lawrence, Leiter, Lawrence A, Cerdas, Sonia, Tong, Cindy, Yee, Jacqueline, Meininger, Gary

    Published in Journal of diabetes and its complications (01-04-2015)
    “…Abstract Aims Canagliflozin, a sodium glucose co-transporter 2 inhibitor, has demonstrated glycemic improvements across studies of patients with type 2…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Clinical case scenarios by Cerdas, Sonia

    Published in Maturitas (01-06-2017)
    Get full text
    Journal Article
  6. 6

    Clinical Features of Adrenocortical Carcinoma, Prognostic Factors, and the Effect of Mitotane Therapy by Luton, Jean-Pierre, Cerdas, Sonia, Billaud, Line, Thomas, Guy, Guilhaume, Brigitte, Bertagna, Xavier, Laudat, Marie-Hélène, Louvel, Albert, Chapuis, Yves, Blondeau, Philippe, Bonnin, André, Bricaire, Henri

    Published in The New England journal of medicine (26-04-1990)
    “…Adrenocortical carcinoma is a rare tumor, and only limited information is available about its natural history and the effects of therapy. We studied 105…”
    Get full text
    Journal Article
  7. 7

    Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates by John, Mathew, Cerdas, Sonia, Violante, Rafael, Deerochanawong, Chaicharn, Hassanein, Mohamed, Slee, April, Canovatchel, William, Hamilton, Gill

    “…Patients with type 2 diabetes mellitus (T2DM) have increased risk of adverse events (AEs; e.g. dehydration, hypoglycaemia) in hot weather. This analysis…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from Latin America by Lavalle-González, Fernando J., Eliaschewitz, Freddy G., Cerdas, Sonia, Del Pilar Chacon, Maria, Tong, Cindy, Alba, Maria

    Published in Current medical research and opinion (03-03-2016)
    “…Objective: This post hoc analysis evaluated the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Efficacy and safety of canagliflozin by baseline HbA1cand known duration of type 2 diabetes mellitus by Wilding, John PH, Blonde, Lawrence, Leiter, Lawrence A, Cerdas, Sonia, Tong, Cindy, Yee, Jacqueline, Meininger, Gary

    Published in Journal of diabetes and its complications (01-04-2015)
    “…Aims Canagliflozin, a sodium glucose co-transporter 2 inhibitor, has demonstrated glycemic improvements across studies of patients with type 2 diabetes…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20